Viewing StudyNCT02245737



Ignite Creation Date: 2024-05-06 @ 3:15 AM
Last Modification Date: 2024-10-26 @ 11:30 AM
Study NCT ID: NCT02245737
Status: TERMINATED
Last Update Posted: 2019-12-03
First Post: 2014-09-18

Brief Title: An Efficacy and Safety Study of Lanabecestat LY3314814 in Early Alzheimers Disease
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Alzheimers Disease
Keywords:
Name View
Tauopathies View
Alzheimers disease View
Dementia View
Brain Diseases View
Neurogenerative Diseases View
Central Nervous System Diseases View
Nervous System Diseases View
Mental Disorders View
Delirium Dementia Amnestic Cognitive Disorders View